Schedule 13G ownership disclosure

DIANTHUS THERAPEUTICS INC COM

Common Stock, par value $0.001 per share · CUSIP: 252828108

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Vestal Point Capital, LP

    Shares: 1,180,000.00 · Class: 3.0%

  • Ryan Wilder

    Shares: 1,180,000.00 · Class: 3.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-25-005000
Form type
SCHEDULE 13G/A
Filer
Dianthus Therapeutics, Inc. /DE/
CIK
CIK 1690585
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub